Treatment of severe alopecia areata with topical diphenylcyclopropenone and 5% minoxidil: a clinical and immunopathologic evaluation.
Shapiro
J
J
University of British Columbia Hair Clinic, Research, Treatment and Transplant Center, Vancouver, Canada.
Tan
J
J
Ho
V
V
Tron
V
V
D000279:Administration, Cutaneous; D000506:Alopecia Areata / Q000188:drug therapy* / Q000276:immunology / Q000473:pathology; D003521:Cyclopropanes / Q000008:administration & dosage / Q000627:therapeutic use*; D004311:Double-Blind Method; D004338:Drug Combinations; D015870:Gene Expression; D006197:Hair / Q000187:drug effects / Q000254:growth & development; D006801:Humans; D018799:Intercellular Adhesion Molecule-1 / Q000187:drug effects / Q000235:genetics; D007801:Langerhans Cells / Q000187:drug effects; D008914:Minoxidil / Q000008:administration & dosage / Q000627:therapeutic use*; D010919:Placebos; D013601:T-Lymphocytes / Q000187:drug effects
D003521:Cyclopropanes; D004338:Drug Combinations; D010919:Placebos; D018799:Intercellular Adhesion Molecule-1; D008914:Minoxidil; C029402:diphenylcyclopropenone